DNA Methylation Near DLGAP2 May Mediate the Relationship between Family History of Type 1 Diabetes and Type 1 Diabetes Risk

Given the differential risk of type 1 diabetes (T1D) in offspring of affected fathers versus affected mothers and our observation that T1D cases have differential DNA methylation near the imprinted DLGAP2 gene compared to controls, we examined whether methylation near DLGAP2 mediates the association between T1D family history and T1D risk. In a nested case–control study of 87 T1D cases and 87 controls from the Diabetes Autoimmunity Study in the Young, we conducted causal mediation analyses at 12 DLGAP2 region CpGs to decompose the effect of family history on T1D risk into indirect and direct effects. These effects were estimated from two regression models adjusted for the human leukocyte antigen DR3/4 genotype: a linear regression of family history on methylation (mediator model) and a logistic regression of family history and methylation on T1D (outcome model). For 8 of the 12 CpGs, we identified a significant interaction between T1D family history and methylation on T1D risk. Accounting for this interaction, we found that the increased risk of T1D for children with affected mothers compared to those with no family history was mediated through differences in methylation at two CpGs (cg27351978, cg00565786) in the DLGAP2 region, as demonstrated by a significant pure natural indirect effect (odds ratio (OR) = 1.98, 95% confidence interval (CI): 1.06–3.71) and nonsignificant total natural direct effect (OR = 1.65, 95% CI: 0.16–16.62) (for cg00565786). In contrast, the increased risk of T1D for children with an affected father or sibling was not explained by DNA methylation changes at these CpGs. Results were similar for cg27351978 and robust in sensitivity analyses. Lastly, we found that DNA methylation in the DLGAP2 region was associated ( P < 0.05 ) with gene expression of nearby protein-coding genes DLGAP2, ARHGEF10, ZNF596, and ERICH1. Results indicate that the maternal protective effect conferred through exposure to T1D in utero may operate through changes to DNA methylation that have functional downstream consequences.

[1]  Ivana V. Yang,et al.  Changes in the Co-Expression of Innate Immunity Genes During Persistent Islet Autoimmunity are Associated with Progression of Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young (DAISY). , 2022, Diabetes.

[2]  V. Tillmann,et al.  Early DNA methylation changes in children developing beta cell autoimmunity at a young age , 2022, Diabetologia.

[3]  J. Ilonen,et al.  Umbilical cord blood DNA methylation in children who later develop type 1 diabetes , 2021, Diabetologia.

[4]  M. Skinner,et al.  Genome-wide CpG density and DNA methylation analysis method (MeDIP, RRBS, and WGBS) comparisons , 2021, Epigenetics.

[5]  G. Seghieri,et al.  Pregnancy outcomes and maternal characteristics in women with pregestational and gestational diabetes: a retrospective study on 206,917 singleton live births , 2021, Acta Diabetologica.

[6]  Ivana V. Yang,et al.  An effective processing pipeline for harmonizing DNA methylation data from Illumina’s 450K and EPIC platforms for epidemiological studies , 2020, BMC research notes.

[7]  A. Prentice,et al.  Effect of maternal preconceptional and pregnancy micronutrient interventions on children's DNA methylation: Findings from the EMPHASIS study , 2020, The American journal of clinical nutrition.

[8]  K. Hemminki,et al.  Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis , 2020, Scientific Reports.

[9]  Ivana V. Yang,et al.  Longitudinal DNA methylation differences precede type 1 diabetes , 2020, Scientific Reports.

[10]  P. Catalano,et al.  Interplay of Placental DNA Methylation and Maternal Insulin Sensitivity in Pregnancy , 2019, Diabetes.

[11]  T. Paus,et al.  Genotype-dependent epigenetic regulation of DLGAP2 in alcohol use and dependence , 2019, Molecular Psychiatry.

[12]  S. Lutz,et al.  Placental DNA Methylation Mediates the Association of Prenatal Maternal Smoking on Birth Weight. , 2019, American journal of epidemiology.

[13]  E. Levin,et al.  Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm , 2019, Epigenetics.

[14]  R. Marioni,et al.  Parent of origin genetic effects on methylation in humans are common and influence complex trait variation , 2019, Nature Communications.

[15]  X. Estivill,et al.  Genome-wide DNA methylation study in human placenta identifies novel loci associated with maternal smoking during pregnancy. , 2016, International journal of epidemiology.

[16]  J. V. van Meurs,et al.  DNA methylation mediates the effect of maternal smoking during pregnancy on birthweight of the offspring , 2015, International journal of epidemiology.

[17]  Emily K. Tsang,et al.  Genetic conflict reflected in tissue-specific maps of genomic imprinting in human and mouse , 2015, Nature Genetics.

[18]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[19]  G. Rutter,et al.  LKB1 and AMPK differentially regulate pancreatic β-cell identity , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  C. Ling,et al.  Genome-Wide Associations between Genetic and Epigenetic Variation Influence mRNA Expression and Insulin Secretion in Human Pancreatic Islets , 2014, PLoS genetics.

[21]  Chia-Hsiang Chen,et al.  Role of the DLGAP2 Gene Encoding the SAP90/PSD-95-Associated Protein 2 in Schizophrenia , 2014, PloS one.

[22]  Jennifer Seifert,et al.  Infant exposures and development of type 1 diabetes mellitus: The Diabetes Autoimmunity Study in the Young (DAISY). , 2013, JAMA pediatrics.

[23]  T. Jones,et al.  Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes , 2013, BMC Pediatrics.

[24]  E. Gale,et al.  The prenatal environment and type 1 diabetes , 2013, Diabetologia.

[25]  Olli Simell,et al.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants , 2011, Pediatric diabetes.

[26]  Stijn Vansteelandt,et al.  Odds ratios for mediation analysis for a dichotomous outcome. , 2010, American journal of epidemiology.

[27]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[28]  Mark Atkinson,et al.  Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method , 2010, PloS one.

[29]  D. Clayton,et al.  The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes , 2009, Nature Genetics.

[30]  Hein Putter,et al.  Persistent epigenetic differences associated with prenatal exposure to famine in humans , 2008, Proceedings of the National Academy of Sciences.

[31]  E. Rampersaud,et al.  Investigating parent of origin effects in studies of type 2 diabetes and obesity. , 2008, Current Diabetes Reviews.

[32]  E. Bonifacio,et al.  Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA1c , 2008, Diabetologia.

[33]  A. Hartemink,et al.  Computational and experimental identification of novel human imprinted genes. , 2007, Genome research.

[34]  J. Tuomilehto,et al.  Differential Transmission of Type 1 Diabetes from Diabetic Fathers and Mothers to Their Offspring , 2006, Diabetes.

[35]  M. Rewers,et al.  Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.

[36]  J. Tuomilehto,et al.  Preferential transmission of type 1 diabetes from parents to offspring: fact or artifact? , 2002, Genetic epidemiology.

[37]  M. Rewers,et al.  Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY) , 1996, Diabetologia.

[38]  M. Rewers,et al.  Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). , 1996, Journal of autoimmunity.

[39]  G. Dahlquist,et al.  Clinical Onset Characteristics of Familial Versus Nonfamilial Cases in a Large Population-based Cohort of Childhood-Onset Diabetes Patients , 1995, Diabetes Care.

[40]  I M Morison,et al.  The imprinted gene and parent-of-origin effect database , 2001, Nucleic Acids Res..

[41]  J. Tuomilehto.  Familial Risk of Type I diabetes in European Children , 1998, Diabetologia.

[42]  G. Vogler,et al.  Investigating genomic imprinting and susceptibility to insulin‐dependent diabetes mellitus: An epidemiologic approach , 1991, Genetic epidemiology.